81_FR_73013 81 FR 72809 - Request for Nominations for Voting Members on a Public Advisory Committee; Food Advisory Committee

81 FR 72809 - Request for Nominations for Voting Members on a Public Advisory Committee; Food Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 204 (October 21, 2016)

Page Range72809-72810
FR Document2016-25497

The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Food Advisory Committee (the Committee), Office of Regulations, Policy, and Social Sciences, Center for Food Safety and Applied Nutrition. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore, encourages nominations of appropriately qualified candidates from these groups.

Federal Register, Volume 81 Issue 204 (Friday, October 21, 2016) 
[Federal Register Volume 81, Number 204 (Friday, October 21, 2016)]
[Notices]
[Pages 72809-72810]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-25497]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]


Request for Nominations for Voting Members on a Public Advisory 
Committee; Food Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for voting members to serve on the Food Advisory Committee 
(the Committee), Office of Regulations, Policy, and Social Sciences, 
Center for Food Safety and Applied Nutrition.
    FDA seeks to include the views of women and men, members of all 
racial and ethnic groups, and individuals with and without disabilities 
on its advisory committees and, therefore, encourages nominations of 
appropriately qualified candidates from these groups.

DATES: Nominations received on or before December 20, 2016, will be 
given first consideration for membership on the Food Advisory 
Committee. Nominations received after December 20, 2016, will be 
considered for nomination to the committee as later vacancies occur.

ADDRESSES: All nominations for membership should be sent electronically 
by logging into the FDA Advisory Committee Membership Nomination 
Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or by mail to Advisory Committee Oversight and Management 
Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
32, Rm. 5103, Silver Spring, MD 20993-0002.

FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for 
membership, the primary contact is: Karen Strambler, 5001 Campus Drive, 
Rm. 1C-008, College Park, MD 20740, email: [email protected], 
240-402-2589, Fax: 301-436-2367.
    Information about becoming a member on an FDA advisory committee 
can also be obtained by visiting FDA's Web site by using the following 
link: http://www.fda.gov/AdvisoryCommittees/default.htm.

SUPPLEMENTARY INFORMATION: FDA is requesting nomination for voting 
members on the Committee.

I. General Description of the Committee Duties

    The Committee reviews and evaluates emerging food safety, 
nutrition, and other food- or cosmetic-related health issues that FDA 
considers of primary importance for its food and cosmetics programs. 
The Committee may be charged with reviewing and evaluating available 
data and making recommendations on matters such as those relating to: 
(1) Broad scientific and technical food- or cosmetic-related issues, 
(2) the safety of food ingredients and new foods, (3) labeling of foods 
and cosmetics, (4) nutrient needs and nutritional adequacy, and (5) 
safe exposure limits for food contaminants. The Committee may also be 
asked to provide advice and make recommendations on ways of 
communicating to the public the potential risks associated with these 
issues and on approaches that might be considered for addressing the 
issues.

II. Criteria for Voting Members

    The Committee consists of a core of 15 voting members including the 
Chair. Members and the Chair are selected by the Commissioner of Food 
and Drugs (the Commissioner) designee from among authorities 
knowledgeable in the fields of physical sciences, biological and life 
sciences, food science, risk assessment, nutrition, food technology, 
molecular biology, epidemiology and other relevant scientific and 
technical disciplines. Members will be invited to serve for overlapping 
terms of up to 4 years. Almost all non-Federal members of this 
Committee serve as Special Government Employees. The core of voting 
members may include two technically qualified member(s), selected by 
the Commissioner or designee, who are identified with consumer 
interests and are recommended by either a consortium of consumer-
oriented organizations or other interested persons. In addition to the 
voting members, the Committee may include two non-voting member(s) who 
are identified with industry interests.

III. Nomination Procedures

    Any interested person may nominate one or more qualified 
individuals for membership on the advisory committee. Self-nominations 
are also accepted. Nominations must include a current, complete 
r[eacute]sum[eacute] or curriculum vitae for each nominee, including 
current business address and/or home address, telephone number, and 
email address if available. Nominations must also

[[Page 72810]]

specify the advisory committee for which the nominee recommended. 
Nominations must also acknowledge that the nominee is aware of the 
nomination unless self-nominated. FDA will ask potential candidates to 
provide detailed information concerning such matters related to 
financial holdings, employment, and research grants and/or contracts to 
permit evaluation of possible sources of conflicts of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: October 18, 2016.
Janice M. Soreth,
Acting Associate Commissioner, Special Medical Programs.
[FR Doc. 2016-25497 Filed 10-20-16; 8:45 am]
BILLING CODE 4164-01-P

Federal Register / Vol. 81, No. 204 / Friday, October 21, 2016 / Notices 72809 sometimes been sent for the wrong identified DHCP letters that were sent hours to prepare and send DHCP letters reasons. and the identity of each sponsor sending in accordance with the guidance. In addition to content and format out a DHCP letter for each year. We In the Federal Register of March 10, recommendations for each type of DHCP estimate that we will receive 2016 (81 FR 12734), we published a 60- letter, the guidance also includes advice approximately 25 DHCP Letters day notice requesting public comment on consulting with FDA to develop a annually from approximately 18 on the proposed extension of this DHCP letter, when to send a letter, what application holders. FDA professionals collection of information. No comments type of letter to send, and conducting an familiar with DHCP letters and with the assessment of the letter’s impact. were received. recommendations in the guidance FDA estimates the annual reporting Based on a review of FDA’s Document Archiving, Reporting and Regulatory estimate that it should take an burden of this collection of information Tracking System for 2012 to 2015, we application holder approximately 100 as follows: TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 Number of re- Average bur- Number of re- Total annual Activity sponses per den per re- Total hours spondents responses respondent sponse (hours) Annual average .................................................................... 18 1.4 25 100 2,500 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Dated: October 17, 2016. Advisory Committee Membership recommendations on ways of Leslie Kux, Nomination Portal: https:// communicating to the public the Associate Commissioner for Policy. www.accessdata.fda.gov/scripts/ potential risks associated with these [FR Doc. 2016–25481 Filed 10–20–16; 8:45 am] FACTRSPortal/FACTRS/index.cfm or by issues and on approaches that might be BILLING CODE 4164–01–P mail to Advisory Committee Oversight considered for addressing the issues. and Management Staff, Food and Drug II. Criteria for Voting Members Administration, 10903 New Hampshire DEPARTMENT OF HEALTH AND Ave., Bldg. 32, Rm. 5103, Silver Spring, The Committee consists of a core of HUMAN SERVICES MD 20993–0002. 15 voting members including the Chair. FOR FURTHER INFORMATION CONTACT: Members and the Chair are selected by Food and Drug Administration Regarding all nomination questions for the Commissioner of Food and Drugs [Docket No. FDA–2016–N–0001] membership, the primary contact is: (the Commissioner) designee from Karen Strambler, 5001 Campus Drive, among authorities knowledgeable in the Request for Nominations for Voting Rm. 1C–008, College Park, MD 20740, fields of physical sciences, biological Members on a Public Advisory email: karen.strambler@fda.hhs.gov, and life sciences, food science, risk Committee; Food Advisory Committee 240–402–2589, Fax: 301–436–2367. assessment, nutrition, food technology, Information about becoming a molecular biology, epidemiology and AGENCY: Food and Drug Administration, member on an FDA advisory committee other relevant scientific and technical HHS. can also be obtained by visiting FDA’s disciplines. Members will be invited to ACTION: Notice. Web site by using the following link: serve for overlapping terms of up to 4 http://www.fda.gov/ years. Almost all non-Federal members SUMMARY: The Food and Drug AdvisoryCommittees/default.htm. of this Committee serve as Special Administration (FDA) is requesting Government Employees. The core of SUPPLEMENTARY INFORMATION: FDA is nominations for voting members to voting members may include two requesting nomination for voting serve on the Food Advisory Committee technically qualified member(s), members on the Committee. (the Committee), Office of Regulations, selected by the Commissioner or Policy, and Social Sciences, Center for I. General Description of the Committee designee, who are identified with Food Safety and Applied Nutrition. Duties consumer interests and are FDA seeks to include the views of The Committee reviews and evaluates recommended by either a consortium of women and men, members of all racial emerging food safety, nutrition, and consumer-oriented organizations or and ethnic groups, and individuals with other food- or cosmetic-related health other interested persons. In addition to and without disabilities on its advisory issues that FDA considers of primary the voting members, the Committee may committees and, therefore, encourages importance for its food and cosmetics include two non-voting member(s) who nominations of appropriately qualified programs. The Committee may be are identified with industry interests. candidates from these groups. charged with reviewing and evaluating DATES: Nominations received on or III. Nomination Procedures available data and making before December 20, 2016, will be given recommendations on matters such as Any interested person may nominate first consideration for membership on those relating to: (1) Broad scientific and one or more qualified individuals for asabaliauskas on DSK3SPTVN1PROD with NOTICES the Food Advisory Committee. technical food- or cosmetic-related membership on the advisory committee. Nominations received after December issues, (2) the safety of food ingredients Self-nominations are also accepted. 20, 2016, will be considered for and new foods, (3) labeling of foods and Nominations must include a current, nomination to the committee as later cosmetics, (4) nutrient needs and complete résumé or curriculum vitae for vacancies occur. nutritional adequacy, and (5) safe each nominee, including current ADDRESSES: All nominations for exposure limits for food contaminants. business address and/or home address, membership should be sent The Committee may also be asked to telephone number, and email address if electronically by logging into the FDA provide advice and make available. Nominations must also VerDate Sep<11>2014 19:06 Oct 20, 2016 Jkt 241001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\21OCN1.SGM 21OCN1

72810 Federal Register / Vol. 81, No. 204 / Friday, October 21, 2016 / Notices specify the advisory committee for including attachments, to http:// claimed confidential information which the nominee recommended. www.regulations.gov will be posted to redacted/blacked out, will be available Nominations must also acknowledge the docket unchanged. Because your for public viewing and posted on http:// that the nominee is aware of the comment will be made public, you are www.regulations.gov. Submit both nomination unless self-nominated. FDA solely responsible for ensuring that your copies to the Division of Dockets will ask potential candidates to provide comment does not include any Management. If you do not wish your detailed information concerning such confidential information that you or a name and contact information to be matters related to financial holdings, third party may not wish to be posted, made publicly available, you can employment, and research grants and/or such as medical information, your or provide this information on the cover contracts to permit evaluation of anyone else’s Social Security number, or sheet and not in the body of your possible sources of conflicts of interest. confidential business information, such comments and you must identify this This notice is issued under the as a manufacturing process. Please note information as ‘‘confidential.’’ Any Federal Advisory Committee Act (5 that if you include your name, contact information marked as ‘‘confidential’’ U.S.C. app. 2) and 21 CFR part 14, information, or other information that will not be disclosed except in relating to advisory committees. identifies you in the body of your accordance with 21 CFR 10.20 and other Dated: October 18, 2016. comments, that information will be applicable disclosure law. For more posted on http://www.regulations.gov. information about FDA’s posting of Janice M. Soreth, • If you want to submit a comment comments to public dockets, see 80 FR Acting Associate Commissioner, Special with confidential information that you Medical Programs. 56469, September 18, 2015, or access do not wish to be made available to the the information at: http://www.fda.gov/ [FR Doc. 2016–25497 Filed 10–20–16; 8:45 am] public, submit the comment as a regulatoryinformation/dockets/ BILLING CODE 4164–01–P written/paper submission and in the default.htm. manner detailed (see ‘‘Written/Paper Docket: For access to the docket to Submissions’’ and ‘‘Instructions’’). read background documents or the DEPARTMENT OF HEALTH AND HUMAN SERVICES Written/Paper Submissions electronic and written/paper comments received, go to http:// Submit written/paper submissions as www.regulations.gov and insert the Food and Drug Administration follows: docket number, found in brackets in the [Docket No. FDA–2010–N–0600] • Mail/Hand delivery/Courier (for heading of this document, into the written/paper submissions): Division of ‘‘Search’’ box and follow the prompts Agency Information Collection Dockets Management (HFA–305), Food and/or go to the Division of Dockets Activities; Proposed Collection; and Drug Administration, 5630 Fishers Management, 5630 Fishers Lane, Rm. Comment Request; Animal Drug User Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments 1061, Rockville, MD 20852. Fee Cover Sheet submitted to the Division of Dockets FOR FURTHER INFORMATION CONTACT: FDA AGENCY: Food and Drug Administration, Management, FDA will post your PRA Staff, Office of Operations, Food HHS. comment, as well as any attachments, and Drug Administration, Three White ACTION: Notice. except for information submitted, Flint North, 10A63, 11601 Landsdown marked and identified, as confidential, St., North Bethesda, MD 20852, SUMMARY: The Food and Drug PRAStaff@fda.hhs.gov. if submitted as detailed in Administration (FDA) is announcing an SUPPLEMENTARY INFORMATION: Under the ‘‘Instructions.’’ opportunity for public comment on the Instructions: All submissions received PRA (44 U.S.C. 3501–3520), Federal proposed collection of certain must include the Docket No. FDA– Agencies must obtain approval from the information by the Agency. Under the 2010–N–0600 for ‘‘Agency Information Office of Management and Budget Paperwork Reduction Act of 1995 (the Collection Activities; Proposed (OMB) for each collection of PRA), Federal Agencies are required to Collection; Comment Request; Animal information they conduct or sponsor. publish notice in the Federal Register Drug User Fee Cover Sheet.’’ Received ‘‘Collection of information’’ is defined concerning each proposed collection of comments will be placed in the docket in 44 U.S.C. 3502(3) and 5 CFR information, including each proposed and, except for those submitted as 1320.3(c) and includes Agency requests extension of an existing collection of ‘‘Confidential Submissions,’’ publicly or requirements that members of the information, and to allow 60 days for viewable at http://www.regulations.gov public submit reports, keep records, or public comment in response to the or at the Division of Dockets provide information to a third party. notice. This notice solicits comments on Management between 9 a.m. and 4 p.m., Section 3506(c)(2)(A) of the PRA (44 the information collection requirements Monday through Friday. U.S.C. 3506(c)(2)(A)) requires Federal of the Animal Drug User Fee cover • Confidential Submissions—To Agencies to provide a 60-day notice in sheet. submit a comment with confidential the Federal Register concerning each DATES: Submit either electronic or information that you do not wish to be proposed collection of information, written comments on the collection of made publicly available, submit your including each proposed extension of an information by December 20, 2016. comments only as a written/paper existing collection of information, ADDRESSES: You may submit comments submission. You should submit two before submitting the collection to OMB copies total. One copy will include the for approval. To comply with this asabaliauskas on DSK3SPTVN1PROD with NOTICES as follows: information you claim to be confidential requirement, FDA is publishing notice Electronic Submissions with a heading or cover note that states of the proposed collection of Submit electronic comments in the ‘‘THIS DOCUMENT CONTAINS information set forth in this document. following way: CONFIDENTIAL INFORMATION.’’ The With respect to the following • Federal eRulemaking Portal: http:// Agency will review this copy, including collection of information, FDA invites www.regulations.gov. Follow the the claimed confidential information, in comments on these topics: (1) Whether instructions for submitting comments. its consideration of comments. The the proposed collection of information Comments submitted electronically, second copy, which will have the is necessary for the proper performance VerDate Sep<11>2014 19:06 Oct 20, 2016 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\21OCN1.SGM 21OCN1


Document Created: 2018-02-13 16:35:52
Document Modified: 2018-02-13 16:35:52
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesNominations received on or before December 20, 2016, will be given first consideration for membership on the Food Advisory Committee. Nominations received after December 20, 2016, will be considered for nomination to the committee as later vacancies occur.
ContactRegarding all nomination questions for membership, the primary contact is: Karen Strambler, 5001 Campus Drive, Rm. 1C-008, College Park, MD 20740, email: [email protected], 240-402-2589, Fax: 301-436-2367.
FR Citation81 FR 72809 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR